Working with producer Kamasi Washington, the Moroccan-born, Los Angeles-based singer channels vintage spiritual jazz on a solo record that feels fresh, literary, and ecstatic. As starting points for ...

The article reveals that MEK’s collaboration with Israel began in 2002 and reached its “peak” during Israel’s 12-day war against Iran. During the war, the group assisted in Israeli strikes on civilian ...

Paris (AFP) – The execution in Iran of two men convicted of carrying out armed operations for an exiled opposition group is a "brutal crime", the group's leader said on Sunday, urging countries to act ...

Maryam Rajavi is president of the National Council of Resistance of Iran (NCRI), the political wing of the People's Mujahedin of Iran, which Tehran regards as a "terrorist" group — Alberto PIZZOLI The ...

The alleged MEK operatives were convicted of manufacturing and using homemade projectiles to target homes, public buildings, and charitable institutions in Tehran. Iran executed two men accused of ...

North African, LA-based singer-songwriter Ami Taf Ra has announced her debut album, The Prophet and The Madman, alongside the release of new single, "How I Became A Madman", featuring Kamasi ...

Over its surprisingly long history (351 years!), German knife maker Böker has established a reputation for producing a wide range of excellent cutlery. Like Specialized in the bike space, the brand ...

Another wave of layoffs will impact Novartis‘ U.S. headquarters in New Jersey. In a filing with the state Department of Labor & Workforce Development, the East Hanover-based Swiss pharmaceutical giant ...

Recent reports indicate that 150 U.S. lawmakers are aligning themselves with the Mojahedin-e Khalq (MEK), an organization with a well-documented history of terrorism, betrayal, and political ...

In a statement to NJBIZ, the company said, “Novartis continually assesses opportunities to drive growth and sustainable performance, and as such, we direct our efforts and talent toward the areas ...

MEK inhibitors are frequently associated with cutaneous adverse events in pediatric patients, and binimetinib was associated with more severe reactions than selumetinib in a retrospective study, which ...

Bottom line: The MEK inhibitor trametinib (Mekinist) was an effective treatment for pediatric patients with relapsed or refractory juvenile myelomonocytic leukemia (JMML) enrolled in a phase II ...